{"id":2786,"date":"2022-05-10T05:46:59","date_gmt":"2022-05-10T05:46:59","guid":{"rendered":"https:\/\/kthholding.se\/?post_type=dt_portfolio&p=2786"},"modified":"2022-06-21T10:18:02","modified_gmt":"2022-06-21T10:18:02","slug":"affibody","status":"publish","type":"dt_portfolio","link":"https:\/\/kthholding.se\/en\/project\/affibody\/","title":{"rendered":"Affibody"},"content":{"rendered":"

[vc_row el_class=”post-row” css=”.vc_custom_1647333135853{padding-top: 55px !important;}”][vc_column][vc_row_inner el_class=”same-row”][vc_column_inner el_class=”get-back”][vc_column_text el_class=”back-link same-row”]<\/p>\n

\n
<\/div>\n<\/div>\n

Back<\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_single_image image=”2784″ img_size=”medium” el_class=”image-padding”][vc_custom_heading source=”post_title” font_container=”tag:h1|text_align:left” el_class=”post-heading”][vc_row_inner][vc_column_inner width=”2\/3″][vc_column_text el_class=”post-text”]<\/p>\n

Affibody is a biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody\u00ae molecules and Albumod\u00ae.<\/p>\n

[\/vc_column_text][\/vc_column_inner][vc_column_inner el_class=”center colored-text” width=”1\/3″][vc_column_text]INVESTMENT<\/strong>
\n1999<\/p>\n

WEBB<\/strong>
\naffibody.se<\/a><\/p>\n

STATUS<\/strong>
\nActive<\/p>\n

TAGS<\/strong>
\nBiotech<\/span>, Pharma<\/span>, [\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

Developing next generation biopharmaceuticals<\/p>\n","protected":false},"author":5,"featured_media":2784,"comment_status":"closed","ping_status":"closed","template":"","dt_portfolio_category":[32],"dt_portfolio_tags":[39,94],"class_list":["post-2786","dt_portfolio","type-dt_portfolio","status-publish","has-post-thumbnail","hentry","dt_portfolio_category-life-science-en","dt_portfolio_tags-biotech","dt_portfolio_tags-pharma","dt_portfolio_category-32","description-off"],"acf":[],"yoast_head":"\nAffibody - KTH Holding AB<\/title>\n<meta name=\"description\" content=\"Affibody is a biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody\u00ae molecules and Albumod\u00ae\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kthholding.se\/en\/project\/affibody\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Affibody - KTH Holding AB\" \/>\n<meta property=\"og:description\" content=\"Affibody is a biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody\u00ae molecules and Albumod\u00ae\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kthholding.se\/en\/project\/affibody\/\" \/>\n<meta property=\"og:site_name\" content=\"KTH Holding AB\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-21T10:18:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kthholding.se\/wp-content\/uploads\/2022\/06\/Affibody.png\" \/>\n\t<meta property=\"og:image:width\" content=\"444\" \/>\n\t<meta property=\"og:image:height\" content=\"114\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"daniel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kthholding.se\/#website\",\"url\":\"https:\/\/kthholding.se\/\",\"name\":\"KTH Holding AB\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kthholding.se\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kthholding.se\/en\/project\/affibody\/#primaryimage\",\"url\":\"https:\/\/kthholding.se\/wp-content\/uploads\/2022\/06\/Affibody.png\",\"contentUrl\":\"https:\/\/kthholding.se\/wp-content\/uploads\/2022\/06\/Affibody.png\",\"width\":444,\"height\":114},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kthholding.se\/en\/project\/affibody\/#webpage\",\"url\":\"https:\/\/kthholding.se\/en\/project\/affibody\/\",\"name\":\"Affibody - KTH Holding AB\",\"isPartOf\":{\"@id\":\"https:\/\/kthholding.se\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kthholding.se\/en\/project\/affibody\/#primaryimage\"},\"datePublished\":\"2022-05-10T05:46:59+00:00\",\"dateModified\":\"2022-06-21T10:18:02+00:00\",\"description\":\"Affibody is a biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody\u00ae molecules and Albumod\u00ae\",\"breadcrumb\":{\"@id\":\"https:\/\/kthholding.se\/en\/project\/affibody\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kthholding.se\/en\/project\/affibody\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kthholding.se\/en\/project\/affibody\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/kthholding.se\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Portfolio\",\"item\":\"https:\/\/kthholding.se\/project\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Affibody\"}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Affibody - KTH Holding AB","description":"Affibody is a biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody\u00ae molecules and Albumod\u00ae","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kthholding.se\/en\/project\/affibody\/","og_locale":"en_US","og_type":"article","og_title":"Affibody - KTH Holding AB","og_description":"Affibody is a biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody\u00ae molecules and Albumod\u00ae","og_url":"https:\/\/kthholding.se\/en\/project\/affibody\/","og_site_name":"KTH Holding AB","article_modified_time":"2022-06-21T10:18:02+00:00","og_image":[{"width":444,"height":114,"url":"https:\/\/kthholding.se\/wp-content\/uploads\/2022\/06\/Affibody.png","type":"image\/png"}],"author":"daniel","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/kthholding.se\/#website","url":"https:\/\/kthholding.se\/","name":"KTH Holding AB","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kthholding.se\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kthholding.se\/en\/project\/affibody\/#primaryimage","url":"https:\/\/kthholding.se\/wp-content\/uploads\/2022\/06\/Affibody.png","contentUrl":"https:\/\/kthholding.se\/wp-content\/uploads\/2022\/06\/Affibody.png","width":444,"height":114},{"@type":"WebPage","@id":"https:\/\/kthholding.se\/en\/project\/affibody\/#webpage","url":"https:\/\/kthholding.se\/en\/project\/affibody\/","name":"Affibody - KTH Holding AB","isPartOf":{"@id":"https:\/\/kthholding.se\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kthholding.se\/en\/project\/affibody\/#primaryimage"},"datePublished":"2022-05-10T05:46:59+00:00","dateModified":"2022-06-21T10:18:02+00:00","description":"Affibody is a biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody\u00ae molecules and Albumod\u00ae","breadcrumb":{"@id":"https:\/\/kthholding.se\/en\/project\/affibody\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kthholding.se\/en\/project\/affibody\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kthholding.se\/en\/project\/affibody\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kthholding.se\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Portfolio","item":"https:\/\/kthholding.se\/project\/"},{"@type":"ListItem","position":3,"name":"Affibody"}]}]}},"_links":{"self":[{"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/dt_portfolio\/2786","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/dt_portfolio"}],"about":[{"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/types\/dt_portfolio"}],"author":[{"embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/comments?post=2786"}],"version-history":[{"count":3,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/dt_portfolio\/2786\/revisions"}],"predecessor-version":[{"id":2958,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/dt_portfolio\/2786\/revisions\/2958"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/media\/2784"}],"wp:attachment":[{"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/media?parent=2786"}],"wp:term":[{"taxonomy":"dt_portfolio_category","embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/dt_portfolio_category?post=2786"},{"taxonomy":"dt_portfolio_tags","embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/dt_portfolio_tags?post=2786"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}